Amgen Cuts The Price Of A Key Drug — Prodding A Rival Biotech To SlideInvestors Business Daily • 10/24/19
Amgen's Latest Data With KRAS G12C Inhibitor Drug Is Mixed, But Can Still Shine On Prior EvidenceSeeking Alpha • 10/10/19
Cancer Results to Watch at This Weekend’s European Society of Medical Oncology CongressThe Motley Fool • 09/27/19